Product Images Marcaine With Epinephrine

This is a description of a pharmaceutical product called "bupvacaine HCl and epinephrine injection, USP" used for infiltration, nerve block, caudal and epidural anesthesia. It is distributed by Hospira Inc. and each mL contains 2.5 mg bupvacaine Hcl and 0.5 mg epinephrine. It contains sodium metal and should be protected from both heat and light. The optimal temperature to store this product is between 20°C and 35°C. The text also contains a product code "PAR1S7277".*

This is a product description of a bupivacaine hydrochloride and epinephrine injection, USP. It is used for infiltration, nerve block, and subdural anesthesia. The dosage of the product is 25mg/10mL (2.5mg/mL) and it contains epinephrine 1:200,000 (as bitartrate). The text also includes information about the usual dosage and storage requirements.*

This is a description of an injection containing bupivacaine hydrochloride and epinephrine, used for infiltration and nerve block. It is distributed by Hospira, Inc. under the name novaplus and contains various substances to make it isotonic and preserve its color and sterility. The dosage instructions are included in the package insert. Lot number and expiration date are also available.*

This is a label of a 50 mL multiple-dose vial containing 0.25% bupivacaine hydrochloride and lopinephrine injection for infiltration and nerve block, but not for caudal, epidural, or intrathecal anesthesia. It contains sulfites and epinephrine 1:200,000 as bitartrate. Dosage instructions are included, and the product should be stored between 15-30°C.*

This is a description of a medication called FROD TS T, which is a 30 mL single dose vial. The medication is preservative-free and is only for injection use. Its NDC number is 0309154107, and it contains bupivacaine hydrochloride and epinephrine. It is used for infiltration, nerve block, caudal and epidural anesthesia. It is manufactured by Novaplus and the lot number is #8#48AA, with an expiration date of DMMMYYYY. In case of unused portion, it should be discarded.*

This is a description of a medical product used for infiltration, nerve block, caudal, and epidural anesthesia. The product contains bupivacaine hydrochloride and epinephrine and is packaged with 10 single dose vials, each containing 30 mL of the solution. The solution contains 75 mg/30 mL (2.5 mg/mL) of bupivacaine hydrochloride and epinephrine 1:200,000 (as bitartrate). It should not be used for intrathecal anesthesia and contains sulfites. Each mL of the solution contains 25 mg bupivacaine HCl and 0.091 g spinephrine bitartrate, with 0.5 g sodium metabisulfite, 0.001 i monobasic sodium phosphate, and 0.082 mg citric acid to adjust pH. The recommended usage dosage is provided in the package. Contains epinephrine - do not autoclave. The unused portion must be discarded after initial use. The product is manufactured or distributed by Hospira, Inc. Novaplus is a registered trademark of Vi, Inc.*

The text appears to be a set of instructions for a medical injection called TPO-2D 15 Wil, with the mixture including bupivacaine hydrochloride and epinephrine. The injection can be used for nerve block, caudal and epidural anesthesia. It is advised to be protected from high temperature, and needles or syringes should not be reused. The solution should be stored at room temperature. It is distributed by Hospira, Inc. Therefore, it seems to be instructions for a particular medical injection.*

This is a description of a medicine containing bupivacaine hydrochloride and epinephrine which is available in 0.5% solution. It can be used for nerve block, caudal, and epidural anesthesia, but not intrathecal anesthesia. The medicine is contained in a package of 10 single-dose vials that are preservative-free. The drug contains sulfites and caution needs to be observed before using it. Sodium metabisulfite, ascorbic acid, calcium disodium, and NaCl are added to make the solution isotonic, and the pH is adjusted with NaOH or HCl. The product should be protected from light and stored at 25°C (77°F). It is distributed by Hospira, Inc. under the brand name “novaplus+”.*

This is a prescription drug information label for Novaplus. It includes details about the drug, such as the NDC number, dosage, and possible applications, such as for nerve block, caudal, and epidural anesthesia. It should not be used for intrathecal anesthesia and is available in a 30 mL Single Dose Vial that is preservative-free. There are also ingredients listed such as calcium chloride dihydrate and NaCl. There is no useful information in the first few lines of text.*

The given text is a description of an injection solution named "bupivacaine hydrochloride and epinephrine injection, USP". The injection solution comes in a pack of 10 single-dose vials, and each vial contains 5 mg/mL of 150 mg/30mL of bupivacaine hydrochloride with epinephrine 1: 200,000. This injection is used for nerve block, caudal, and epidural anesthesia. The package contains a warning that it contains sulfites. The description also includes usual dosage instructions, instructions for storage, and information on the distribution company.*

This is a description of a medical product called "bupivacaine hydrochloride and lepinephrine injection, USP". The product is stored at room temperature and the recommended dosage can be found in the package insert. It is distributed by Hospira, located in Lake Foreet, L 0045 USA. The product comes in a colorless, clear solution and should be stored between 20 and 25°C. The label shows a FPO-GS1 DataBar Limited 10 mil and a lot number (PAA187511).*

This is a medication label containing information on bupivacaine hydrochloride and epinephrine injection used for nerve block. It comes in a 50 mL Multiple-Dose Vial containing 0.5% of the active ingredients 250 mg/50 mL (5 mg/mL) with epinephrine 1:200,000 (as bitartrate). The medication is not recommended for cauda, epidural, or intrathecal anesthesia. It is intended to protect the product from light as the solution is supposed to be clear and colorless. The label displays information on storage conditions, chemical composition, dosage, and manufacturer registration.*